Well, they'll have a lot of room to do that --- if the R/S is approved, the new OS will be about 4,386,950 shares, and the AS would be 850mil shares ... a lot of room for issuing shares.
But, the company got a dose of reality. In the past, an announcement re: an acquisition or a LOI to acquire would generate a lot of interest and days of 100s of millions of shares traded. As we have seen with the last two announcements of the LOI for the Skin Scientific Co & the fitness supplement product, volume has been either non-existent or a paltry amount is traded.
So now it's another lesson in Supply & Demand ... when you oversupply with shares, and time passes and revs & profits do not significantly improve, but you still want to acquire (I assume with shares), eventually you will lose the demand.
Sure, there will be fewer newly issued notes at .25 than would be at a "trips" (.0001) price, but if no one is interested in buying --- it ain't gonna matter.
